Start-ups Chair Anthony Millin judges first annual Bio+Tech Conference in Baltimore
September 24, 2018
As part of the event, a pitch competition was held featuring innovative biotechnology companies from across Maryland. CEO Greg Crimmins of Remedy Plan Therapeutics won the competition.
“The judges were very impressed with the quality of all five companies who pitched and were excited to see the potential these companies bring to Maryland,” Anthony Millin, a judge of the contest who chairs startups and venture capital for Shulman Rogers. “We were specifically impressed with Remedy Plan Therapeutics and the team’s innovative approach to cancer research.”